The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems

Trends in Pharmacological Sciences

Volumn 37, Issue 4, 2016, Pages 262-278

  Su, Tsung Ping ^a   Su, Tzu Chieh ^a   Nakamura, Yoki ^a   Tsai, Shang Yi ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

diseases; pluripotent modulator; sigma 1 receptor

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; ANKYRIN; BETA1 INTEGRIN; BINDING IMMUNOGLOBULIN PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CANNABINOID 1 RECEPTOR; CELL PROTEIN; DOPAMINE RECEPTOR; EMERIN; GUANOSINE TRIPHOSPHATASE; HEAT SHOCK PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MU OPIATE RECEPTOR; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; POTASSIUM CHANNEL KV1.3; POTASSIUM CHANNEL KV1.4; PROTEIN ELMOD; PROTEIN IRE1; RAS RELATED C3 BOTULINUM TOXIN SUBSTRATE GUANOSINE TRIPHOSPHATASE; SIGMA 1 OPIATE RECEPTOR; SIGMA RECEPTOR AGONIST; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

ACTION POTENTIAL; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANALGESIC ACTIVITY; ANTIDEPRESSANT ACTIVITY; BINDING AFFINITY; CELL ADHESION; CELL MEMBRANE; COCAINE DEPENDENCE; DEPRESSION; DRUG MECHANISM; ENDOPLASMIC RETICULUM MEMBRANE; ENDOPLASMIC RETICULUM STRESS; HUNTINGTON CHOREA; MOTONEURON; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SPINAL CORD VENTRAL HORN; SYNAPTIC TRANSMISSION; AGONISTS; ANIMAL; ENDOPLASMIC RETICULUM; HUMAN; METABOLISM; MITOCHONDRION; MOLECULARLY TARGETED THERAPY;

ANIMALS; ENDOPLASMIC RETICULUM; HUMANS; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; RECEPTORS, SIGMA;

EID: 84957894818     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2016.01.003     Document Type: Review

References (141)

1. W.R. Martin, and et al. The effects of morphine- A nd nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog J. Pharmacol. Exp. Ther. 197 1976 517 532
2. T.P. Su Evidence for sigma opioid receptor: Binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain J. Pharmacol. Exp. Ther. 223 1982 284 290
3. T.P. Su, and et al. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems Science 240 1988 219 221
4. S.B. Hellewell, and W.D. Bowen A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain Brain Res. 527 1990 244 253
5. M. Hanner, and et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site Proc. Natl. Acad. Sci. U.S.A. 93 1996 8072 8077
6. J. Xu, and et al. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site Nat. Commun. 2 2011 380
7. T. Hayashi, and T.P. Su Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival Cell 131 2007 596 610
8. D. Boehning, and et al. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis Nat. Cell Biol. 5 2003 1051 1061
9. H. Tagashira, and et al. Fluvoxamine rescues mitochondrial Ca2+ transport and ATP production through sigma(1)-receptor in hypertrophic cardiomyocytes Life Sci. 95 2014 89 100
10. T. Mori, and et al. Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival PLoS ONE 8 2013 e76941
11. J. Wang, and et al. Sigma 1 receptor regulates the oxidative stress response in primary retinal Muller glial cells via NRF2 signaling and system x, the Na-independent glutamate-cystine exchanger Free Radic. Biol. Med. 86 2015 25 36
12. T.P. Su, and et al. The sigma-1 receptor chaperone as an inter-organelle signaling modulator Trends Pharmacol. Sci. 31 2010 557 566
13. U. Chu, and A.E. Ruoho Biochemical pharmacology of the sigma-1 receptor Mol. Pharmacol. 89 2015 142 153
14. T.A. Mavlyutov, and et al. Subcellular localization of the sigma-1 receptor in retinal neurons - A n electron microscopy study Sci. Rep. 5 2015 10689
15. S.A. Tsai, and et al. Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope Proc. Natl. Acad. Sci. U.S.A. 112 2015 E6562 E6570
16. Y. Herrera, and et al. Sigma-1 receptor modulation of acid-sensing ion channel a (ASIC1a) and ASIC1a-induced Ca2+ influx in rat cortical neurons J. Pharmacol. Exp. Ther. 327 2008 491 502
17. S.M. Carnally, and et al. Demonstration of a direct interaction between sigma-1 receptors and acid-sensing ion channels Biophy. J. 98 2010 1182 1191
18. G. Navarro, and et al. Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine Proc. Natl. Acad. Sci. U.S.A. 107 2010 18676 18681
19. E. Moreno, and et al. Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: Sigma1-D1-H3 receptor complexes as key targets for reducing cocaine's effects J. Neurosci. 34 2014 3545 3558
20. G. Navarro, and et al. Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers PLoS ONE 8 2013 e61245
21. T.A. Mavlyutov, and et al. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study Neuroscience 167 2010 247 255
22. C.C. Chien, and G.W. Pasternak Sigma antagonists potentiate opioid analgesia in rats Neurosci. Lett. 190 1995 137 139
23. C.C. Chien, and G.W. Pasternak Selective antagonism of opioid analgesia by a sigma system J. Pharmacol. Exp. Ther. 271 1994 1583 1590
24. C.C. Chien, and G.W. Pasternak Functional antagonism of morphine analgesia by (+)-pentazocine: Evidence for an anti-opioid sigma 1 system Eur. J. Pharmacol. 250 1993 R7 R8
25. J. Mei, and G.W. Pasternak Sigma1 receptor modulation of opioid analgesia in the mouse J. Pharmacol. Exp. Ther. 300 2002 1070 1074
26. J. Mei, and G.W. Pasternak Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: A microinjection study J. Pharmacol. Exp. Ther. 322 2007 1278 1285
27. F.J. Kim, and et al. Sigma 1 receptor modulation of G-protein-coupled receptor signaling: Potentiation of opioid transduction independent from receptor binding Mol. Pharmacol. 77 2010 695 703
28. M. Rodriguez-Munoz, and et al. The sigma1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control Antioxid. Redox Signal. 22 2015 799 818
29. R. Bergeron, and et al. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: Effects mediated via sigma receptors J. Neurosci. 16 1996 1193 1202
30. M. Martina, and et al. The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus J. Physiol. 578 2007 143 157
31. D. Balasuriya, and et al. The sigma-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1/GluN2A NMDA receptor J. Neurosci. 33 2013 18219 18224
32. M. Pabba, and et al. NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus J. Neurosci. 34 2014 11325 11338
33. P. Sanchez-Blazquez, and et al. The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: Implications in antinociception and psychotic diseases Int. J. Neuropsychopharmacol. 17 2014 1943 1955
34. K. Hashimoto Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression Prog. Neurobiol. 100 2013 15 29
35. M. Fujimoto, and et al. Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor Synapse 66 2012 630 639
36. Y. Kimura, and et al. Sigma-1 receptor enhances neurite elongation of cerebellar granule neurons via TrkB signaling PLoS ONE 8 2013 e75760
37. H. Yao, and et al. Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule: Implication for increased monocyte adhesion and migration in the CNS J. Neurosci. 31 2011 5942 5955
38. C.P. Palmer, and et al. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines Cancer Res. 67 2007 11166 11175
39. E. Aydar, and et al. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit Neuron 34 2002 399 410
40. M. Kinoshita, and et al. Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands Brain Res. 1452 2012 1 9
41. S. Kourrich, and et al. Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine Cell 152 2013 236 247
42. D. Crottes, and et al. Sig1R protein regulates hERG channel expression through a post-translational mechanism in leukemic cells J. Biol. Chem. 286 2011 27947 27958
43. D. Balasuriya, and et al. A direct interaction between the sigma-1 receptor and the hERG voltage-gated K+ channel revealed by atomic force microscopy and homogeneous time-resolved fluorescence (HTRF(R)) J. Biol. Chem. 289 2014 32353 32363
44. D. Balasuriya, and et al. The sigma-1 receptor binds to the Nav1.5 voltage-gated Na+ channel with 4-fold symmetry J. Biol. Chem. 287 2012 37021 37029
45. X.F. Gao, and et al. Sigma-1 receptor agonists directly inhibit Nav1.2/1.4 channels PLoS ONE 7 2012 e49384
46. M. Johannessen, and et al. Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems Am. J. Physiol. Cell Physiol. 296 2009 C1049 C1057
47. M. Johannessen, and et al. Antagonist action of progesterone at sigma-receptors in the modulation of voltage-gated sodium channels Am. J. Physiol. Cell Physiol. 300 2011 C328 C337
48. G.C. Brailoiu, and et al. Cocaine inhibits store-operated Ca2+ entry in brain microvascular endothelial cells: Critical role for sigma-1 receptors Biochem. J. 473 2015 1 5
49. A.A. Ivanova, and et al. Characterization of recombinant ELMOD (cell engulfment and motility domain) proteins as GTPase-activating proteins (GAPs) for ARF family GTPases J. Biol. Chem. 289 2014 11111 11121
50. S.Y. Tsai, and et al. Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway Proc. Natl. Acad. Sci. U.S.A. 106 2009 22468 22473
51. N. Natsvlishvili, and et al. Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria BMC Biochem. 16 2015 11
52. J.L. Ortega-Roldan, and et al. Characterization of the human sigma-1 receptor chaperone domain structure and binding immunoglobulin protein (BiP) interactions J. Biol. Chem. 288 2013 21448 21457
53. L.Y. Bourguignon, and H. Jin Identification of the ankyrin-binding domain of the mouse T-lymphoma cell inositol 1,4,5-trisphosphate (IP3) receptor and its role in the regulation of IP3-mediated internal Ca2+ release J. Biol. Chem. 270 1995 7257 7260
54. T. Hayashi, and T.P. Su Regulating ankyrin dynamics: Roles of sigma-1 receptors Proc. Natl. Acad. Sci. U.S.A. 98 2001 491 496
55. K.S. Marriott, and et al. sigma-1 receptor at the mitochondrial-associated endoplasmic reticulum membrane is responsible for mitochondrial metabolic regulation J. Pharmacol. Exp. Ther. 343 2012 578 586
56. M. Prasad, and et al. Mitochondria-associated endoplasmic reticulum membrane (MAM) regulates steroidogenic activity via steroidogenic acute regulatory protein (StAR)-voltage-dependent anion channel 2 (VDAC2) interaction J. Biol. Chem. 290 2015 2604 2616
57. L. Hedskog, and et al. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models Proc. Natl. Acad. Sci. U.S.A. 110 2013 7916 7921
58. T. Hayashi, and et al. The lifetime of UDP-galactose:ceramide galactosyltransferase is controlled by a distinct endoplasmic reticulum-associated degradation (ERAD) regulated by sigma-1 receptor chaperones J. Biol. Chem. 287 2012 43156 43169
59. D. Dussossoy, and et al. Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level Eur. J. Biochem. 263 1999 377 386
60. T. Hayashi, and T.P. Su Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells J. Pharmacol. Exp. Ther. 306 2003 726 733
61. T. Schmitt, and et al. FunCoup 3.0: Database of genome-wide functional coupling networks Nucleic Acids Res. 42 2014 D380 D388
62. A. Chatr-Aryamontri, and et al. The BioGRID interaction database: 2015 update Nucleic Acids Res. 43 2015 D470 D478
63. D. Szklarczyk, and et al. STRING v10: Protein-protein interaction networks, integrated over the tree of life Nucleic Acids Res. 43 2015 D447 D452
64. S.Y. Tsai, and et al. Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope Proc. Natl. Acad. Sci. U.S.A. 112 2015 E6562 E6570
65. N. Bernard-Marissal, and et al. Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration Brain 138 2015 875 890
66. C. Taghibiglou, and et al. Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide Biochem. Biophys. Res. Commun. 413 2011 159 163
67. N. Pierrot, and et al. Amyloid precursor protein controls cholesterol turnover needed for neuronal activity EMBO Mol. Med. 5 2013 608 625
68. C.A. Tamminga, and A. Carlsson Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis Curr. Drug Targets CNS Neurol. Disord. 1 2002 141 147
69. K. Sahlholm, and et al. Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses Psychopharmacology 232 2015 3443 3453
70. V. Francardo, and et al. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism Brain 137 2014 1998 2014
71. C.H. Duman, and et al. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment Biol. Psychiatry 61 2007 661 670
72. R.J. Liu, and et al. Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex Biol. Psychiatry 71 2012 996 1005
73. S.Y. Tsai, and et al. Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid Proc. Natl. Acad. Sci. U.S.A. 112 2015 6742 6747
74. K.A. Gromek, and et al. The oligomeric states of the purified sigma-1 receptor are stabilized by ligands J. Biol. Chem. 289 2014 20333 20344
75. A.K. Mishra, and et al. The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands Biochem. J. 466 2015 263 271
76. A. Al-Saif, and et al. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis Ann. Neurol. 70 2011 913 919
77. V.V. Belzil, and et al. Genetic analysis of SIGMAR1 as a cause of familial ALS with dementia Eur. J. Hum. Genet. 21 2013 237 239
78. C. Casas, and et al. Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis Brain Behav. 3 2013 145 158
79. K. Fukunaga, and et al. The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis J. Pharmacol. Sci. 127 2015 36 41
80. Y. Iguchi, and et al. Amyotrophic lateral sclerosis: An update on recent genetic insights J. Neurol. 260 2013 2917 2927
81. H.J. Kim, and et al. Mutations in UBQLN2 and SIGMAR1 genes are rare in Korean patients with amyotrophic lateral sclerosis Neurobiol. Aging 35 2014 e1957 e1958 1957
82. Z.J. Liu, and et al. Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system Neurobiol. Aging 35 2014 e2811 e2885 2881
83. R. Mancuso, and et al. Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G(9)(3)A ALS mice: Overlapping effects or limited therapeutic opportunity? Orphanet J. Rare Dis. 9 2014 78
84. R. Mancuso, and et al. Sigma-1R agonist improves motor function and motoneuron survival in ALS mice Neurotherapeutics 9 2012 814 826
85. T.A. Mavlyutov, and et al. Lack of sigma-1 receptor exacerbates ALS progression in mice Neuroscience 240 2013 129 134
86. T.A. Mavlyutov, and et al. Role of the sigma-1 receptor in amyotrophic lateral sclerosis (ALS) J. Pharmacol. Sci. 127 2015 10 16
87. Y. Ono, and et al. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models Neurosci. Lett. 559 2014 174 178
88. M. Peviani, and et al. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation Neurobiol. Dis. 62 2014 218 232
89. J. Prause, and et al. Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis Hum. Mol. Genet. 22 2013 1581 1600
90. H. Tagashira, and et al. Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis Biochim. Biophys. Acta 1840 2014 3320 3334
91. S.Y. Tsai, and et al. Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders Expert Opin. Ther. Targets 18 2014 1461 1476
92. M.I. Ullah, and et al. In silico analysis of SIGMAR1 variant (rs4879809) segregating in a consanguineous Pakistani family showing amyotrophic lateral sclerosis without frontotemporal lobar dementia Neurogenetics 16 2015 299 306
93. J.T. Vollrath, and et al. Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances Cell Death Dis. 5 2014 e1290
94. A.A. Behensky, and et al. Afobazole activation of sigma-1 receptors modulates neuronal responses to amyloid-beta25-35 J. Pharmacol. Exp. Ther. 347 2013 468 477
95. T. Furuse, and K. Hashimoto Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease Ann. Gen. Psychiatry 9 2010 6
96. V. Lahmy, and et al. Blockade of Tau hyperphosphorylation and Abeta(1)(-)(4)(2) generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and sigma(1) receptor agonist, in a nontransgenic mouse model of Alzheimer's disease Neuropsychopharmacology 38 2013 1706 1723
97. J. Yin, and et al. Sigma-1 (sigma(1)) receptor deficiency reduces beta-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B Neuropharmacology 89 2015 215 224
98. H. Yao, and et al. Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: Implication for increased monocyte transmigration Blood 115 2010 4951 4962
99. S. Buch, and et al. Cocaine and HIV-1 interplay in CNS: Cellular and molecular mechanisms Curr. HIV Res. 10 2012 425 428
100. S.G. Kim, and et al. Cocaine exposure enhances permissiveness of quiescent T cells to HIV infection J. Leukoc. Biol. 94 2013 835 843
101. Y. Zhang, and et al. Sigma-1 receptor agonists provide neuroprotection against gp120 via a change in bcl-2 expression in mouse neuronal cultures Brain Res. 1431 2012 13 22
102. Y. Zhang, and et al. Involvement of sigma-1 receptor in astrocyte activation induced by methamphetamine via up-regulation of its own expression J. Neuroinflammation 12 2015 29
103. X. Zhang, and et al. Cocaine enhances HIV-1 gp120-induced lymphatic endothelial dysfunction in the lung Physiol. Rep. 3 2015 e12482
104. A. Hyrskyluoto, and et al. Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: Involvement of calpastatin and the NF-kappaB pathway Cell Death Dis. 4 2013 e646
105. Y. Miki, and et al. Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease Neurobiol. Dis. 74 2015 25 31
106. F. Squitieri, and et al. Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model J. Cell. Mol. Med. 19 2015 2540 2548
107. F. Squitieri, and J.G. de Yebenes Profile of pridopidine and its potential in the treatment of Huntington disease: The evidence to date Drug Des. Devel. Ther. 9 2015 5827 5833
108. D.H. Roh, and et al. Sigma-1 receptor-induced increase in murine spinal NR1 phosphorylation is mediated by the PKCalpha and epsilon, but not the PKCzeta, isoforms Neurosci. Lett. 477 2010 95 99
109. S.Y. Yoon, and et al. An increase in spinal dehydroepiandrosterone sulfate (DHEAS) enhances NMDA-induced pain via phosphorylation of the NR1 subunit in mice: Involvement of the sigma-1 receptor Neuropharmacology 59 2010 460 467
110. L.F. Tseng, and et al. (+)-Morphine attenuates the (-)-morphine-produced tail-flick inhibition via the sigma-1 receptor in the mouse spinal cord Life Sci. 89 2011 875 877
111. F.R. Nieto, and et al. Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice J. Pain 13 2012 1107 1121
112. L. Romero, and et al. Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization Br. J. Pharmacol. 166 2012 2289 2306
113. M.L. Bangaru, and et al. Sigma-1 receptor expression in sensory neurons and the effect of painful peripheral nerve injury Mol. Pain 9 2013 47
114. S.R. Choi, and et al. Spinal sigma-1 receptors activate NADPH oxidase 2 leading to the induction of pain hypersensitivity in mice and mechanical allodynia in neuropathic rats Pharmacol. Res. 74 2013 56 67
115. J.Y. Moon, and et al. Sigma-1 receptor-mediated increase in spinal p38 MAPK phosphorylation leads to the induction of mechanical allodynia in mice and neuropathic rats Exp. Neurol. 247 2013 383 391
116. J.Y. Moon, and et al. sigma1 receptors activate astrocytes via p38 MAPK phosphorylation leading to the development of mechanical allodynia in a mouse model of neuropathic pain Br. J. Pharmacol. 171 2014 5881 5897
117. B. Pan, and et al. Sigma-1 receptor antagonism restores injury-induced decrease of voltage-gated Ca2+ current in sensory neurons J. Pharmacol. Exp. Ther. 350 2014 290 300
118. D.H. Roh, and S.Y. Yoon Sigma-1 receptor antagonist, BD1047 reduces nociceptive responses and phosphorylation of p38 MAPK in mice orofacial formalin model Biol. Pharm. Bull. 37 2014 145 151
119. C. Sanchez-Fernandez, and et al. Modulation of peripheral mu-opioid analgesia by sigma1 receptors J. Pharmacol. Exp. Ther. 348 2014 32 45
120. A. Vidal-Torres, and et al. Effects of the selective sigma-1 receptor antagonist S1RA on formalin-induced pain behavior and neurotransmitter release in the spinal cord in rats J. Neurochem. 129 2014 484 494
121. J.Y. Moon, and et al. Spinal sigma-1 receptor activation increases the production of d-serine in astrocytes which contributes to the development of mechanical allodynia in a mouse model of neuropathic pain Pharmacol. Res. 100 2015 353 364
122. T. Mori, and et al. Effects of (+)-pentazocine on the antinociceptive effects of (-)-pentazocine in mice Synapse 69 2015 166 171
123. K. Ruscher, and et al. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke Brain 134 2011 732 746
124. J. Hong, and et al. Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons Cell Death Dis. 6 2015 e1832
125. T. Kishi, and et al. Association analysis of SIGMAR1 with major depressive disorder and SSRI response Neuropharmacology 58 2010 1168 1173
126. M. Nakano, and et al. Fluvoxamine and sigma-1 receptor agonists dehydroepiandrosterone (DHEA)-sulfate induces the Ser473-phosphorylation of Akt-1 in PC12 cells Life Sci. 86 2010 309 314
127. N. Chevallier, and et al. Behavioural phenotyping of knockout mice for the sigma-1 (sigma(1)) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations J. Psychopharmacol. 25 2011 960 975
128. M. Elfverson, and et al. Chronic administration of the anabolic androgenic steroid nandrolone alters neurosteroid action at the sigma-1 receptor but not at the sigma-2 or NMDA receptors Neuropharmacology 61 2011 1172 1181
129. T. Hayashi, and et al. Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders Expert Opin. Ther. Targets 15 2011 557 577
130. J. Sabeti Ethanol exposure in early adolescence inhibits intrinsic neuronal plasticity via sigma-1 receptor activation in hippocampal CA1 neurons Alcohol. Clin. Exp. Res. 35 2011 885 904
131. V. Villard, and et al. Pharmacological interaction with the sigma1 (sigma1)-receptor in the acute behavioral effects of antidepressants J. Pharmacol. Sci. 115 2011 279 292
132. Y. Albayrak, and K. Hashimoto Beneficial effects of the sigma-1 agonist fluvoxamine for tardive dyskinesia in patients with postpsychotic depressive disorder of schizophrenia: Report of 5 cases The primary care companion for CNS disorders 14 2012 12br01401
133. Y. Fu, and et al. Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice Biochim. Biophys. Acta 1823 2012 826 837
134. K. Ito, and et al. Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression Cardiovas. Res. 93 2012 33 40
135. T. Niitsu, and et al. A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: A preliminary study J. Clin. Psychopharmacol. 32 2012 593 601
136. S. Moriguchi, and et al. Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice PLoS ONE 8 2013 e60863
137. M. Allahtavakoli, and B. Jarrott Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats Brain Res. Bull. 85 2011 219 224
138. K. Ruscher, and et al. Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydro-chloride on inflammation after stroke PLoS ONE 7 2012 e45118
139. S. Sato, and et al. Antidepressant fluvoxamine reduces cerebral infarct volume and ameliorates sensorimotor dysfunction in experimental stroke Neuroreport 25 2014 731 736
140. R. Urfer, and et al. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke Stroke 45 2014 3304 3310
141. H. Dong, and et al. Sigma-1 receptor modulates neuroinflammation after traumatic brain injury Cell. Mol. Neurobiol. 2015 10.1007/s10571-015-0244-0 Published online July 31, 2015